X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
77
PharmaCompass offers a list of Levetiracetam API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Levetiracetam manufacturer or Levetiracetam supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Levetiracetam manufacturer or Levetiracetam supplier.
PharmaCompass also assists you with knowing the Levetiracetam API Price utilized in the formulation of products. Levetiracetam API Price is not always fixed or binding as the Levetiracetam Price is obtained through a variety of data sources. The Levetiracetam Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Levetiracetam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levetiracetam, including repackagers and relabelers. The FDA regulates Levetiracetam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levetiracetam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levetiracetam manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levetiracetam supplier is an individual or a company that provides Levetiracetam active pharmaceutical ingredient (API) or Levetiracetam finished formulations upon request. The Levetiracetam suppliers may include Levetiracetam API manufacturers, exporters, distributors and traders.
click here to find a list of Levetiracetam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Levetiracetam DMF (Drug Master File) is a document detailing the whole manufacturing process of Levetiracetam active pharmaceutical ingredient (API) in detail. Different forms of Levetiracetam DMFs exist exist since differing nations have different regulations, such as Levetiracetam USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Levetiracetam DMF submitted to regulatory agencies in the US is known as a USDMF. Levetiracetam USDMF includes data on Levetiracetam's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Levetiracetam USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Levetiracetam suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Levetiracetam Drug Master File in Japan (Levetiracetam JDMF) empowers Levetiracetam API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Levetiracetam JDMF during the approval evaluation for pharmaceutical products. At the time of Levetiracetam JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Levetiracetam suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Levetiracetam Drug Master File in Korea (Levetiracetam KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Levetiracetam. The MFDS reviews the Levetiracetam KDMF as part of the drug registration process and uses the information provided in the Levetiracetam KDMF to evaluate the safety and efficacy of the drug.
After submitting a Levetiracetam KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Levetiracetam API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Levetiracetam suppliers with KDMF on PharmaCompass.
A Levetiracetam CEP of the European Pharmacopoeia monograph is often referred to as a Levetiracetam Certificate of Suitability (COS). The purpose of a Levetiracetam CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Levetiracetam EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Levetiracetam to their clients by showing that a Levetiracetam CEP has been issued for it. The manufacturer submits a Levetiracetam CEP (COS) as part of the market authorization procedure, and it takes on the role of a Levetiracetam CEP holder for the record. Additionally, the data presented in the Levetiracetam CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Levetiracetam DMF.
A Levetiracetam CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Levetiracetam CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Levetiracetam suppliers with CEP (COS) on PharmaCompass.
A Levetiracetam written confirmation (Levetiracetam WC) is an official document issued by a regulatory agency to a Levetiracetam manufacturer, verifying that the manufacturing facility of a Levetiracetam active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Levetiracetam APIs or Levetiracetam finished pharmaceutical products to another nation, regulatory agencies frequently require a Levetiracetam WC (written confirmation) as part of the regulatory process.
click here to find a list of Levetiracetam suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Levetiracetam as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Levetiracetam API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Levetiracetam as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Levetiracetam and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Levetiracetam NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Levetiracetam suppliers with NDC on PharmaCompass.
Levetiracetam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levetiracetam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levetiracetam GMP manufacturer or Levetiracetam GMP API supplier for your needs.
A Levetiracetam CoA (Certificate of Analysis) is a formal document that attests to Levetiracetam's compliance with Levetiracetam specifications and serves as a tool for batch-level quality control.
Levetiracetam CoA mostly includes findings from lab analyses of a specific batch. For each Levetiracetam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levetiracetam may be tested according to a variety of international standards, such as European Pharmacopoeia (Levetiracetam EP), Levetiracetam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levetiracetam USP).
Market Place
